[go: up one dir, main page]

ATE461915T1 - Substituierte (e)-styrylbenzylsulfone zur behandlung proliferativer erkrankungen - Google Patents

Substituierte (e)-styrylbenzylsulfone zur behandlung proliferativer erkrankungen

Info

Publication number
ATE461915T1
ATE461915T1 AT01977567T AT01977567T ATE461915T1 AT E461915 T1 ATE461915 T1 AT E461915T1 AT 01977567 T AT01977567 T AT 01977567T AT 01977567 T AT01977567 T AT 01977567T AT E461915 T1 ATE461915 T1 AT E461915T1
Authority
AT
Austria
Prior art keywords
sub
alkoxy
halogen
phosphonato
sulfamyl
Prior art date
Application number
AT01977567T
Other languages
English (en)
Inventor
E Reddy
M Reddy
Original Assignee
Univ Temple
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Temple filed Critical Univ Temple
Application granted granted Critical
Publication of ATE461915T1 publication Critical patent/ATE461915T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/18—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/02—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms
    • C07C317/10—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01977567T 2000-10-05 2001-10-05 Substituierte (e)-styrylbenzylsulfone zur behandlung proliferativer erkrankungen ATE461915T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23822200P 2000-10-05 2000-10-05
PCT/US2001/031337 WO2002028828A1 (en) 2000-10-05 2001-10-05 Substituted (e)-styryl benzylsulfones for treating proliferative disorders

Publications (1)

Publication Number Publication Date
ATE461915T1 true ATE461915T1 (de) 2010-04-15

Family

ID=22896982

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01977567T ATE461915T1 (de) 2000-10-05 2001-10-05 Substituierte (e)-styrylbenzylsulfone zur behandlung proliferativer erkrankungen

Country Status (8)

Country Link
US (1) US7053123B2 (de)
EP (1) EP1328511B1 (de)
JP (1) JP2004510761A (de)
AT (1) ATE461915T1 (de)
AU (1) AU2001296677A1 (de)
CA (1) CA2424884C (de)
DE (1) DE60141641D1 (de)
WO (1) WO2002028828A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548553B2 (en) * 1997-10-03 2003-04-15 Temple University-Of The Commonwealth System Of Higher Education Styryl sulfone anticancer agents
US6767926B1 (en) * 1999-10-12 2004-07-27 Temple University - Of The Commonwealth System Of Higher Education Method for protecting normal cells from cytotoxicity of chemotherapeutic agents
JP4538233B2 (ja) * 2002-02-28 2010-09-08 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション 増殖性障害治療用の、アミノ置換されたスルホンアニリド及びその誘導体
US7598232B2 (en) 2002-02-28 2009-10-06 Temple University - Of The Commonwealth System Of Higher Education Amino-substituted (E)-2,6-dialkoxystyryl 4-substituted-benzylsulfones for treating proliferative disorders
AU2004289281C1 (en) * 2003-11-14 2011-12-08 Onconova Therapeutics, Inc. Alpha, beta-Unsaturated sulfoxides for treating proliferative disorders
HUE030786T2 (en) 2004-03-16 2017-06-28 Temple Univ - Of The Commonwealth System Of Higher Education Substituted phenoxy and phenylthio derivatives for the treatment of proliferative disorders
US8058313B2 (en) 2004-06-24 2011-11-15 Temple University—Of the Commonwealth System of Higher Education Alpha, beta-unsaturated sulfones, sulfoxides, sulfonimides, sulfinimides, acylsulfonamides and acylsulfinamides and therapeutic uses thereof
JP5278968B2 (ja) 2006-08-30 2013-09-04 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション 骨髄異形性症候群及び急性骨髄性白血病の治療のための組成物及び方法
CN110776447A (zh) 2012-09-20 2020-02-11 坦普尔大学 取代的烷基二芳基衍生物、制备方法和用途
EP2928456B1 (de) 2012-12-07 2021-02-03 Onconova Therapeutics, Inc. Behandlung einer gegenüber einem anti-krebsmittel refraktären hämatologischen krebserkrankung
US10383831B2 (en) 2015-08-03 2019-08-20 Temple University—Of the Commonwealth System of Higher Education 2,4,6-trialkoxystryl aryl sulfones, sulfonamides and carboxamides, and methods of preparation and use

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2532612A (en) 1945-08-29 1950-12-05 Union Oil Co Preparation of unsaturated thio-ethers
US3185743A (en) 1960-08-24 1965-05-25 Union Carbide Corp Production of olefinic compounds from allyl sulfones
US3463774A (en) 1963-03-18 1969-08-26 Hoffmann La Roche Novel 4,1-benzothiazepin-2-(1h)-ones and 4,1-benzothiazepines
US3418101A (en) 1965-12-15 1968-12-24 Pennsalt Chemicals Corp Process for plant desiccation
US3514386A (en) 1967-12-11 1970-05-26 Exxon Research Engineering Co Stereoselective addition of thiols to acetylenic compounds
US3917714A (en) 1972-09-06 1975-11-04 American Cyanamid Co Bis(alkylsulfonyl)vinylbenzenes
US4161407A (en) 1977-10-06 1979-07-17 Eastman Kodak Company Crosslinkable polymers having vinylsulfonyl groups or styrylsulfonyl groups and their use as hardeners for gelatin
US4386221A (en) 1981-10-28 1983-05-31 Eastman Kodak Company Process for the preparation of aryl alkyl sulfones and aryl vinyl sulfones
US4937388A (en) 1985-08-09 1990-06-26 Imperial Chemical Industries Plc Insecticidal ethers
US5659087A (en) 1995-06-07 1997-08-19 Eli Lilly And Company Diarylvinyl sulfoxides
US5733909A (en) 1996-02-01 1998-03-31 Merck Frosst Canada, Inc. Diphenyl stilbenes as prodrugs to COX-2 inhibitors
US6030961A (en) * 1997-03-11 2000-02-29 Bar-Ilan Research & Development Co., Ltd. Oxyalkylene phosphate compounds and uses thereof
US6548553B2 (en) 1997-10-03 2003-04-15 Temple University-Of The Commonwealth System Of Higher Education Styryl sulfone anticancer agents
KR100579355B1 (ko) 1997-10-03 2006-05-12 템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 스티릴 설폰 항암제
US6201154B1 (en) 1999-03-31 2001-03-13 Temple University-Of The Commonwealth Of Higher Education Z-styryl sulfone anticancer agents
US6762207B1 (en) * 1999-04-02 2004-07-13 Temple University - Of The Commonwealth System Of Higher Education (E)-styryl sulfone anticancer agents
US6418101B1 (en) * 1999-09-03 2002-07-09 Zen Research (Ireland), Ltd. Digital read channel for optical disk reader
US6767926B1 (en) * 1999-10-12 2004-07-27 Temple University - Of The Commonwealth System Of Higher Education Method for protecting normal cells from cytotoxicity of chemotherapeutic agents
AU780844B2 (en) 1999-10-12 2005-04-21 Temple University-Of The Commonwealth System Of Higher Education Method for protecting normal cells from cytotoxicity of chemotherapeutic agents
US6486210B2 (en) 2000-04-14 2002-11-26 Temple University—Of the Commonwealth System of Higher Education Substituted styryl benzylsulfones for treating proliferative disorders
US6541475B2 (en) * 2000-04-14 2003-04-01 Temple University - Of The Commonwealth System Of Higher Education α, β-unsaturated sulfones for treating proliferative disorders
EP1370253B8 (de) 2001-02-28 2008-11-26 Temple University of the Commonwealth System of Higher Education Verwendung von alpha, beta ungesättigten arylsulfonen zum schutz von zellen und geweben vor toxizität ionischer strahlung

Also Published As

Publication number Publication date
WO2002028828A1 (en) 2002-04-11
US20050101528A1 (en) 2005-05-12
CA2424884C (en) 2009-12-15
EP1328511A1 (de) 2003-07-23
US7053123B2 (en) 2006-05-30
CA2424884A1 (en) 2002-04-11
JP2004510761A (ja) 2004-04-08
EP1328511B1 (de) 2010-03-24
AU2001296677A1 (en) 2002-04-15
DE60141641D1 (de) 2010-05-06
EP1328511A4 (de) 2005-11-30

Similar Documents

Publication Publication Date Title
WO2001064639A3 (en) Pde iv inhibiting amides, compositions and pharmaceutical use
BR0211910A (pt) Derivados de tiazolila 2,4,5-trissubstituìdos e a atividade antiinflamatória dos mesmos
EP1248612A4 (de) Neue substanzen und verbindungen als protease-inhibitoren
TW200420549A (en) Thiazole derivatives
HRP20090162T1 (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
EP1340755A4 (de) Mittel mit wirkung gegen helicobacter
AU2002246728A1 (en) Carboline derivatives
BR0309342A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
ATE461915T1 (de) Substituierte (e)-styrylbenzylsulfone zur behandlung proliferativer erkrankungen
AU2002213421A1 (en) Condensed pyridoindole derivatives
AU2001266575A1 (en) Chemical compounds
EE200000472A (et) Kasvajavastased toimeained
AU1182702A (en) Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same
PT1272481E (pt) 4-trifluorometil-2h-benzopiranos antiestrogenicos com accao estrogenica selectiva
SE0301320D0 (sv) Positive modulators of nicotinic acetylcholine receptors
EA200301203A1 (ru) Новые соединения и композиции как ингибиторы катепсина
SE0003476D0 (sv) Compounds
ATE417856T1 (de) Motilidverbindungen
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
AU2001296699A1 (en) Condensed pyrazindione derivatives as pde inhibitors
AU2002211493A1 (en) Indole derivatives as pde5-inhibitors
BR0112957A (pt) Composto, método de tratamento, uso de um composto, e, composição farmacêutica
NO20032411D0 (no) Anvendelse av substituerte 6-dimetylaminometyl-1-fenyl- cykloheksan-forbindelser for behandling av urininkontinens
NO20032407D0 (no) Anvendelse av 6-dimetylaminometyl-1-fenyl- cykloheksanforbindelser for behandling av urininkontinens
MXPA05003909A (es) Compuestos de benzopiranona, composiciones de los mismos, y metodos para el tratamiento o prevencion del cancer.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties